euticals (TKMR US) — Investment Stance: Positive PT C$67 March 2014 Company overview: Tekmira Pharmaceuticals is a leading RNA interference (RNAi) Therapeutics Company with more than 14 years of industry experience. The Company has good revenue potential via its pipeline of product candidates in development to tre